Thomas McLaughlin
Psychiatry · Lawrence, MANPI 1518062827
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 323 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,080 and has fallen 97.7% since, to $70 in 2022. Among psychiatry clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 323 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Johnson & Johnson$982
- AbbVie$716
- Alkermes, Inc.$484
- Shire North American Group Inc$290
- Lundbeck LLC$287
- plus $1K from 13 others
What the payments were for
- Food & beverage$5,16498%
- Education$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 49 | $1,064 |
| Johnson & Johnson | 57 | $982 |
| AbbVie(2 entities) | 55 | $716 |
| Alkermes, Inc. | 22 | $484 |
| Shire North American Group Inc | 34 | $290 |
| Lundbeck LLC | 20 | $287 |
| Vanda Pharmaceuticals Inc. | 12 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $216 |
| Neos Therapeutics, LP | 12 | $178 |
| Neurocrine Biosciences, Inc. | 8 | $174 |
| Teva Pharmaceuticals USA, Inc. | 8 | $164 |
| Sunovion Pharmaceuticals Inc. | 11 | $141 |
| Avanir Pharmaceuticals, Inc. | 4 | $73 |
| Merck | 5 | $68 |
| Neuronetics, Inc. | 2 | $55 |
| Jazz Pharmaceuticals Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $38 |
| Orexo US, Inc. | 2 | $26 |
| Eisai Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$116
How this compares
$5,254 in reported general payments places this provider in the 90th percentile of 1,431 psychiatry providers in Massachusetts.
Other psychiatry in Lawrence
- Theresa CerulliNorth Andover$724K
- Andrew AldridgeMedford$407K
- Amjad BahnassiWorcester$352K
- Ximena Sanchez-SamperBoston$258K
- Robert AlexanderBelmont$170K
- George PapakostasBoston$170K
- Xiangyang LiMilford$166K
- Ernesto ZilberbergNorth Andover$141K
- Maurizio FavaBoston$120K
- Craig SurmanCambridge$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.